Bulls & Betrayal

Fortrea Holdings $FTRE spun off from LabCorp with bold promises of growth and profitability—but insiders now face a lawsuit over alleged securities fraud. In this episode of Bulls & Betrayal, we dive into missed earnings, crumbling contract pipelines, and insider stock sales—all while the company talked up tech upgrades and margin magic. Perfect for investors, biotech watchers, and Wall Street accountability junkies. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Hit ZLK.com for more on the case and follow us for the next corporate faceplant.

Civitas Resources $CIVI promised strong production and growth—but behind the scenes, well counts dropped, debt ballooned, and executives vanished. In this episode of Bulls & Betrayal, we expose how upbeat forecasts masked real operational decline and why investors are now suing over sudden stock losses and surprise layoffs. If you’re into energy markets, corporate accountability, or just love a good Wall Street takedown, this one’s for you. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Check out ZLK.com to learn more or join the class action.

Biotech hopeful Iovance $IOVA promised a blockbuster launch of its cancer drug Amtagvi—forecasting nearly half a billion in revenue. But when reality hit, it came crashing down. In this episode of Bulls & Betrayal, we uncover how lofty projections, slow treatment rollout, and alleged internal knowledge of infrastructure issues led to a brutal 45% stock plunge. Ideal for investors, healthcare analysts, and corporate truth-seekers. Expect biotech drama, class action insights, and sharp market analysis. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Learn more or join the case at ZLK.com

Red Cat Holdings $RCAT soared on drone hype, military contracts, and big promises—but now it’s facing investor lawsuits, insider sell-offs, and claims of massive exaggeration. In this episode of Bulls & Betrayal, we unpack the alleged deception behind “thousands of drones,” a $260M contract fantasy, and a reality crash that clipped investor wings. Ideal for investors, military-tech watchers, and truth seekers. Expect sharp storytelling, legal drama, and behind-the-scenes breakdowns. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Get the full story and join the case at ZLK.com 

DoubleVerify $DV claimed to protect brands from bot traffic—but now it’s accused of billing for ads shown to obvious bots and losing major clients. In this episode of Bulls & Betrayal, we dive into a digital deception unraveling across Wall Street. Perfect for adtech skeptics, investors, and truth-hunters who want the real story behind stock drops and lawsuits. Expect insider analysis, sharp wit, and zero fluff. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Visit ZLKcom to join the class action and follow for more financial fraud breakdowns.

Krispy Kreme $DNUT said investors would be "rolling in the dough"—but now it’s lawsuits and losses. This episode of Bulls & Betrayal dives into the frosted fiasco behind the $33 million miss and tanking stock. Perfect for retail investors, finance sleuths, and anyone craving corporate accountability. Expect sharp banter, deep dives, and a dash of comedy. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Visit ZLK.com to learn more about the class action, and follow us for more stock scandal exposés.

When $CAR Avis Budget Group accelerated its fleet rotation strategy, it didn’t just switch out cars—it wiped nearly $2 billion off the books in one quarter. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, we break down the class action lawsuit accusing Avis of misleading investors by hiding the true financial impact of its fleet decisions. Perfect for investors, finance pros, and corporate accountability watchers. Expect deep dives and sharp analysis. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Learn more at ZLK.com.

Organon $OGN promised investors dividends were priority number one—then slashed payouts by over 70%. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, we dig into the lawsuit claiming Organon misled shareholders while quietly shifting gears to pay down debt. If you’re into dividend stocks, corporate trust, or securities law drama, this episode’s for you. Expect sharp commentary and deep dives. We’re not lawyers or accountants, so don’t take this as legal or financial advice. More info at ZLK.com.

A major class action lawsuit is rocking $BITF Bitfarms Ltd, the Bitcoin mining company accused of misclassifying over $129 million in crypto proceeds and misleading investors about internal financial controls. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, Cassie and Bill break down what Bitfarms allegedly did wrong, who’s suing, and what this could mean for the crypto mining industry. Perfect for crypto investors, market watchdogs, and anyone into financial accountability. Expect sharp commentary and deep dives. We’re not lawyers or accountants, so don’t take this as legal or financial advice. More at ZLK.com.

Ever read a securities lawsuit and feel like it's written in code? In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate decode the essential legal lingo like 10b-5, scienter, materiality, and loss causation that powers shareholder lawsuits. Whether you're an investor, law student, or just curious how the financial system polices itself, this episode is your go-to translation guide. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Subscribe now and visit ZLK.com to stay sharp on your shareholder rights.

Ever wonder why some CEOs get sued while others get cuffed? In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate unpack the crucial difference between civil and criminal cases in securities fraud. From class actions to DOJ indictments, they explore how intent, evidence, and consequences define the legal response. Perfect for investors, law students, and true crime meets finance fans. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Subscribe now and visit ZLK.com for more on shareholder rights.

In this episode of Bulls and Betrayal: Holding Wall Street Accountable, we dive into the courtroom role of expert witnesses in securities fraud cases. From economic loss models to industry insights, these finance-savvy pros can make or break billion-dollar lawsuits. Whether you're an investor, law junkie, or just curious how fraud cases unfold, we’ve got sharp analysis and plain-English breakdowns. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Subscribe and visit ZLK.com for more on investor rights and class actions.

When shady spreadsheets meet their match, forensic accountants step in. In this episode of Bulls and Betrayal: Holding Wall Street Accountable, we break down the role of these financial sleuths in exposing securities fraud. From fake invoices to sham revenue, these experts uncover the truth behind the numbers. Ideal for investors, legal buffs, and finance pros. Expect real-world examples, expert insights, and some serious accounting drama. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Learn more at ZLK.com.

West Pharmaceutical $WST took a brutal 38% hit in one day after investors learned the company’s golden goose its SmartDose line was dragging profits, not boosting them. In this episode of Bulls and Betrayal: Holding Wall Street Accountable, we unpack how upbeat earnings calls masked a structural downturn and shrinking contracts, sparking a major securities class action. Perfect for biotech investors, analysts, and market skeptics. Expect sharp insights, legal context, and straight talk. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Explore more at ZLK.com.

Digimarc $DMRC shocked the market with a 43% stock drop after revealing a lost $5.8M contract they'd failed to disclose for months. In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Cassie and Bill break down the alleged cover-up, the class action lawsuit, and what it means for tech investors. Perfect for shareholders, finance buffs, and legal junkies. Expect deep dives, sharp banter, and no-fluff facts. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Visit ZLK.com to learn more or see if you're part of the class.

In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Cassie and Bill unpack the explosive story behind Compass Diversified’s luxury brand Lugano Diamonds. Once hailed as a crown jewel, $CODI stock plummeted over 60% amid federal class action allegations of misleading investors, flawed financial controls, and a shocking CEO resignation. Perfect for investors, finance enthusiasts, and corporate watchdogs. Expect sharp commentary and deep dives into real-world market drama. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Learn more at ZLK.com.

When buzzwords meet balance sheets, things can go south fast. In this episode of Bulls & Betrayal, Cassie and Bill unpack the class action against $IBTA Ibotta after its alleged failure to disclose a key contract risk involving grocery giant Kroger. Investors claim they were misled during the flashy IPO. If you’re into financial drama, Wall Street accountability, or just want the lowdown on how IPOs can unravel, this is for you. Expect sharp banter, deep dives, and brutal honesty. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Subscribe and follow us @bullsandbetrayal.

GlaxoSmithKline $GSK allegedly hid a decades-old report showing its blockbuster drug Zantac could form a cancer-causing compound far beyond safe limits. Now, a securities class action says $GSK misled investors for years while lawsuits mounted. In this explosive episode of Bulls and Betrayal, Anna and Nate expose the cover-up, the internal science, and the $2.3B market hit. For pharma investors, legal junkies, and anyone who’s ever trusted a drug label. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🔬 Read the full case at ZLK.com | Follow @bullsandbetrayal $GSK GlaxoSmithKline Zantac NDMA cancer lawsuit drug recall pharma scandal securities fraud shareholder class action FDA litigation whistleblower toxic risk disclosure Emma Walmsley Rule 10b5

Ultra Clean Holdings $UCTT promised explosive semiconductor growth in China—then stunned the market with a surprise earnings drop and a 28% stock plunge. On this episode of Bulls and Betrayal, Anna and Nate dig into the class action lawsuit alleging $UCTT hid slowdowns, inventory issues, and customer ramp failures behind bullish calls and inflated forecasts. For tech investors, market skeptics, and finance truth-seekers, this is must-listen content. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 📉 Full case details at ZLK.com | Follow @bullsandbetrayal $UCTT Ultra Clean Holdings semiconductor lawsuit China demand earnings call stock drop SEC violation investor fraud class action 10b5 CFO CEO disclosure rule misrepresentation fabrication

Solaris Energy Infrastructure $SEI turned heads with a $400M acquisition—of a company with no employees, no real assets, and ties to a convicted felon. In this episode of Bulls and Betrayal, Anna and Nate dissect the shocking class action lawsuit alleging Solaris misled investors about MER’s legitimacy, cooked depreciation math, and hid toxic baggage (literally). Perfect for shareholders, corporate governance junkies, and true crime meets finance fans. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🔎 Dive deeper at ZLK.com | Follow @bullsandbetrayal $SEI Solaris Energy MER class action scandal acquisition fraud turbine leasing John Tuma environmental crimes depreciation manipulation shell company SEC disclosure investor lawsuit corporate due diligence failure

Open Lending $LPRO promised fintech innovation and bulletproof loan modeling—then reported a shocking $57M revenue loss and a 57% stock crash. In this episode of Bulls and Betrayal, Anna and Nate dig into the class action lawsuit alleging $LPRO misled investors with inflated profit share projections and flawed credit risk models. If you're into fintech, auto lending, or financial transparency, this one's for you. We break down earnings bombs, AI model failure, and leadership shakeups. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🔍 Follow @bullsandbetrayal | Case details at ZLK.com $LPRO Open Lending fintech lawsuit profit share model defaults AI credit risk class action stock crash auto loans SEC financial reporting transparency predictive modeling

Napco Security Technologies $NSSC promised soaring margins and booming hardware sales—but was it all smoke and mirrors? This week on Bulls and Betrayal, Anna and Nate unpack the class action lawsuit alleging $NSSC misled investors with inflated forecasts and faulty financial guidance. If you’re an investor, market skeptic, or just love seeing corporate facades crack, this one’s for you. We dig into earnings calls, margin promises, and the $NSSC stock plunge. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🔎 Follow @bullsandbetrayal | Full case at ZLK.com $NSSC Napco Security hardware sales earnings miss margin projections shareholder lawsuit stock crash class action Exchange Act distributor slowdown securities fraud Wall Street accountability

NET Power $NPWR claimed it had a zero-emission power plant lighting the way to a green future. But was their La Porte demo site even running? In this episode of Bulls and Betrayal, Anna and Nate expose the shareholder lawsuit alleging $NPWR misrepresented key facts during its SPAC merger. Perfect for retail investors, clean energy enthusiasts, and legal watchers. Expect deep dives, timeline breakdowns, and corporate accountability—SPAC-style. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 💼 Follow us @bullsandbetrayal | Visit ZLK.com for more $NPWR NET Power SPAC lawsuit demo plant La Porte zero emissions green energy securities fraud clean tech shareholder class action power generation Rice Acquisition Corp deceptive disclosures NYSE

Zenas BioPharma $ZBIO dazzled Wall Street with its biotech promise—but did it deceive investors from the start? This week on Bulls and Betrayal, Anna and Nate unravel the class action lawsuit claiming $ZBIO overstated its financial runway and misled buyers during its 2024 IPO. If you're a retail investor, legal aficionado, or just love a juicy Wall Street exposé, this one’s for you. Expect sharp commentary, deep dives, and accountability served cold. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Subscribe and follow @bullsandbetrayal | Visit ZLK.com for more. Keywords: $ZBIO Zenas BioPharma IPO lawsuit biotech stock fraud class action securities underwriter due diligence shareholder rights Wall Street deception

🌿 CGC in the Weeds How Canopy Growth Lost 529 Million in Inventory WriteDowns This week on Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate unpack the lawsuit facing Canopy Growth Corporation (Ticker: CGC). With a shocking $529 million inventory write-down and a net loss of $648 million, investors are alleging they were misled—and they’re fighting back. Perfect for cannabis investors, legal watchers, and financial truth-seekers. Expect a wild ride through corporate smoke screens, SEC filings, and market fallout. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🔥 Visit ZLK.com for more and follow us for more high-stakes financial drama!

💊 $VTRS Vanishing Act The 26 Billion Dollar Write-Down Wall Street Forgot to Mention In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate unravel the Viatris Inc (Ticker: $VTRS) merger drama—where bold earnings talk clashed with a stunning $25.8 billion goodwill impairment on the very same day. Was it poor communication, or a case of corporate misdirection? Perfect for investors, compliance pros, and anyone tracking post-merger fallout. Expect sharp commentary, lawsuit insights, and jaw-dropping financial reveals. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🔍 More at ZLK.com and follow us for future fraud deep dives!

$TMCI Trouble Toe-Tal: The Bunion Scandal Wall Street Didn’t See Coming In this explosive episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate dive into the class action lawsuit shaking up Treace Medical Concepts Inc (Ticker: $TMCI). Allegations of securities fraud, misleading investor claims, and “bunion-sized” deception over their Lapiplasty system make this a case investors can’t ignore. Perfect for investors, financial sleuths, or anyone curious about corporate accountability. Expect sharp commentary, lawsuit breakdowns, and a touch of humor. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🔍 For more, visit ZLK.com and follow us for more financial deep dives!

🎙️Title: "BBAI - When AI Gets Audited: BigBear’s Accounting Faceplant" When BigBear.ai ($BBAI) stumbled over basic accounting, investors didn’t just lose money they lost trust. In this episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate dig into how one of the hottest AI stocks misapplied bifurcated accounting, misled the markets, and sparked a class-action lawsuit. If you’re a retail investor, stock market junkie, or just love a good financial scandal, this one’s for you. Expect sharp commentary, financial drama, and expert-level breakdowns—with zero jargon. 📢 We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🔍 SEO: BigBear.ai, BBAI stock, securities lawsuit, accounting fraud, class action, stockholder rights, Wall Street scandal

AbbVie offers $45 a share. Just weeks earlier, Bain buys millions of Cerevel (CERE) shares at $22.81. Coincidence or insider edge? In this explosive episode of Bulls and Betrayal: Holding Wall Street Accountable, Anna and Nate dive into a biotech merger turning heads in court. If you’re an investor, legal buff, or just love corporate drama, this episode is for you. Expect class action twists, SPAC games, and profit plays that smell fishy. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 👉 More at ZLK.com 

What happens when a company allegedly hides a $200M valuation before selling for just $110M? In this episode of Bulls and Betrayal: Holding Wall Street Accountable, we dive into the ECG Management Consultants lawsuit. Nate and Anna unpack allegations of fiduciary breaches, hidden valuations, and shareholder deception—all without a stock ticker in sight. Perfect for investors, finance sleuths, and corporate accountability junkies. Expect legal drama, big numbers, and sharp analysis (with a side of humor). 👉 Visit ZLK.com for more on securities litigation. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Constellation Brands (STZ), the powerhouse behind Corona and Meiomi, is facing a bombshell securities fraud lawsuit—and we’re diving deep into the billions at stake. This episode of Bulls & Betrayal unpacks how overly rosy projections about their wine and spirits business may have misled investors. Stockholders lost big, and now they’re fighting back. Perfect for retail investors, finance followers, and anyone hooked on corporate drama. Expect sharp analysis, no-fluff breakdowns, and investigative storytelling. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Subscribe & learn more at ZLK.com

Quantum Computing Inc. ($QUBT) promised futuristic tech, NASA deals, and chip foundries—but investors may have bought into fiction, not function. In this Bulls & Betrayal episode, we uncover how a startup hyped a “quantum leap” only to be hit with a class action lawsuit for alleged fraud, fake revenue, and phantom facilities. If you're a retail investor, tech optimist, or just love a good financial exposé, you won’t want to miss this deep dive into one of quantum’s shadiest chapters. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Listen now | Learn more at ZLK.com | Follow @BullsBetrayal

Manhattan Associates ($MANH) looked unstoppable—record revenue, booming cloud growth, and bold projections. But behind the scenes, they were allegedly hyping a services segment they knew couldn’t deliver. This episode of Bulls & Betrayal dives into the class action lawsuit claiming misleading guidance led to a brutal 24.49% stock crash and major investor losses. If you're into SaaS stocks, corporate accountability, or Wall Street smoke and mirrors, this one’s for you. Expect sharp insights, real talk, and no sugarcoating. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Subscribe now & learn more at ZLK.com | Follow @BullsBetrayal

Zynex ($ZYXI) made headlines for more than just back pain relief — a new class action lawsuit alleges they sent patients excessive medical supplies to inflate revenues, sparking insurance backlash and a stock collapse. From padded bills to Tricare suspensions, this episode of Bulls & Betrayal uncovers how a billing scheme may have zapped shareholder value. If you're into healthcare stocks, investor rights, or scandalous financial reveals, this one’s for you. Expect deep dives, dry wit, and class action clarity. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Follow @BullsBetrayal | More at ZLK.com

Sana Biotechnology ($SANA) claimed a long cash runway and a thriving clinical pipeline — but investors were blindsided when two flagship programs were scrapped and nearly a third of the workforce got cut. In this episode of Bulls & Betrayal, we dissect the timeline, the SEC filings, and the class action lawsuit that’s now accusing Sana of securities fraud. Perfect for biotech investors, legal junkies, and financial sleuths, this episode delivers sharp analysis and storytelling with just the right dose of biotech drama. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Subscribe & learn more at ZLK.com | Follow us @BullsBetrayal

SoundHound AI ($SOUN) went from powering voice assistants to facing a full-blown shareholder class action lawsuit — and this episode breaks down how it all unraveled. From botched acquisitions and internal control failures to a stock drop and SEC filings, we're diving into what really happened behind the scenes. If you're an investor, finance nerd, legal junkie, or startup watcher, this one's for you. Expect deep dives, sharp commentary, and a few well-placed puns. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Subscribe, share, and follow us @BullsBetrayal | More at ZLK.com

Grocery Outlet (GO) promised a smooth systems upgrade—but investors got a rude awakening when stock prices plummeted nearly 20% overnight. In this episode of Bulls & Betrayal, Anna and Nate unpack how a botched tech rollout, misleading statements, and delayed admissions led to a federal securities class action lawsuit. Was it corporate misstep... or deception? Perfect for retail investors, watchdogs, and anyone tracking corporate accountability. Expect sharp insights, real talk, and a breakdown of the Securities Exchange Act in action. 💼 We’re not lawyers or accountants, so don’t take this as legal or financial advice. 📍 Visit ZLK.com for more

Novo Nordisk (NVO) made waves with promises of 25% weight loss from its new drug CagriSema—but when final trial results dropped below expectations, investors were blindsided. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, Anna and Nate dig into the REDEFINE-1 study, “flexible protocols,” and the class action lawsuit that followed. If you're an investor, financial sleuth, or anyone tracking pharma giants and stock fraud, this one’s for you. Expect deep dives, candid takes, and no sugar-coating. 💼 We’re not lawyers or accountants, so don’t take this as legal or financial advice. 👀 Learn more at ZLK.com

One of agri-science’s biggest names, FMC Corporation ($FMC), is in hot water—think securities fraud, inventory deception, and a 33% stock nosedive. This episode of Bulls & Betrayal dives deep into the class action lawsuit, what went wrong, and what it means for investors. Perfect for retail traders, market watchers, and legal-curious listeners. Expect sharp banter, hard facts, and a juicy Wall Street takedown. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 💼 Presented by Levi & Korsinsky visit ZLK.com for more info 📲 Follow @BullsAndBetrayal for updates and new episodes

What happens when a logistics giant starts losing high-margin clients and doesn’t tell investors? In this episode of Bulls & Betrayal: Holding Wall Street Accountable, Anna and Nate unpack the explosive class action lawsuit against TFI International (NYSE:TFII). With a 20%+ stock crash and eyebrow-raising executive quotes like “a dog chasing his tail,” this one’s a must-listen for investors, finance sleuths, and corporate accountability hawks. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Get the full breakdown of missed warnings, freight division troubles, and legal fallout 💼 Presented by Levi & Korsinsky visit ZLK.com for more info 📲 Follow @BullsAndBetrayal for updates and new episodes

A shocking 27% single-day drop, massive CRE write-downs, and now... a class action lawsuit. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, hosts Anna and Nate unpack the sudden implosion of Ready Capital (NYSE:RC), from confident earnings calls to a full-on financial faceplant. Perfect for investors, finance watchdogs, and curious market followers, this episode delivers a dramatic deep dive into alleged misleading disclosures, executive accountability, and the mechanics of securities litigation. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Listen for sharp commentary, timeline breakdowns, and insights on who might be impacted. Hit subscribe and stay skeptical. 🔎 Learn more or check your eligibility at ZLK.com

When Maravai LifeSciences (MRVI) misreported $3.9 million in revenue, it wasn’t just a bad math day—it triggered a stock crash and a class-action lawsuit. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, Anna and Nate break down how mistimed revenue, goodwill impairments, and “effective internal controls” turned into investor nightmares. If you're a retail investor, finance nerd, or just love some forensic accounting drama, this deep dive is for you. We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Catch the full breakdown + more at ZLK.com and follow us on socials for updates.

In today’s episode, we unpack the $MRK securities fraud lawsuit that’s shaking Wall Street. Investors claim Merck misled them about Gardasil vaccine sales in China, sparking a major stock price crash. This deep dive is perfect for investors, traders, and corporate accountability followers. Expect sharp analysis, lawsuit breakdowns, and insider insights. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Subscribe now for more stock news, legal updates, and investment deep-dives. Visit ZLK.com for more info!

Crocs (NASDAQ: CROX) is in hot water after investors filed a securities fraud lawsuit, accusing the company of misleading them about the financial success of its $2.5B HeyDude acquisition. This episode of Bulls & Betrayal breaks down the case, why the stock tanked, and what it means for shareholders. Perfect for retail investors, finance enthusiasts, and market watchdogs, we deliver sharp analysis and eye-opening details. (Interviews, deep dives, and a touch of skepticism included.) 🚨 We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🚨 Subscribe for updates and visit ZLK.com for more info!

IIPR stock tanked over 20% twice. Why? In this episode of Bulls & Betrayal, Anna and Nate unpack the class action lawsuit against Innovative Industrial Properties (IIPR), a cannabis-focused REIT accused of misleading investors. If you're an investor, financial sleuth, or curious about securities fraud, tune in for legal deep dives, real talk, and expert-backed insights. Presented by Levi & Korsinsky. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Subscribe now or visit ZLK.com for more.

Semtech’s CopperEdge tech was supposed to be a game-changer—until it wasn’t. In this episode of Bulls & Betrayal, we break down the shocking 31% stock plunge, the lawsuit that followed, and what it means for investors. If you held SMTC stock or follow corporate accountability, this one’s for you. Expect deep dives, expert insight, and a no-BS breakdown of investor claims and executive missteps. 🚨 We’re not lawyers or accountants, so don’t take this as legal or financial advice. 🎧 Follow us for more on securities fraud, class actions, and corporate drama. 🔗 Sponsored by Levi & Korsinsky | Visit ZLK.com

Was fintech darling Block, Inc. fueling its growth by ignoring financial crime? In this explosive episode of Bulls & Betrayal: Holding Wall Street Accountable, we dive into a bombshell lawsuit alleging the company behind Square and Cash App enabled fraud, money laundering—even worse. Perfect for investors, fintech watchers, and true crime finance fans, this episode blends whistleblower drama, deep-dive reporting, and regulatory chaos. 👉 Visit ZLK.com for more. Subscribe & stay sharp. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Was Intellia Misleading Investors? The NTLA-3001 Lawsuit Explained In this episode of Bulls & Betrayal, Anna and Nate break down the explosive class action lawsuit against Intellia Therapeutics. Investors allege the company hyped a failing gene-editing program—NTLA-3001—while hiding key industry shifts. If you’re into Wall Street drama, biotech trends, or protecting your portfolio, this one’s for you. Expect deep dives, sharp analysis, and a dash of outrage. Subscribe & follow us @BullsAndBetrayal. We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Bulls & Betrayal: Holding Wall Street Accountable exposes the corporate cover-ups and securities fraud lawsuits that shake the markets. Hosted by Anna and Nate, this podcast is for investors, financial sleuths, and corporate accountability junkies who want to understand what really happens when Wall Street bends the truth. Each episode dives into real world cases like ICON PLC’s alleged deception over lost contracts and insider stock dumps with clear, engaging storytelling and sharp analysis. No legal jargon. No sugarcoating. Just deep dives into shareholder lawsuits, SEC filings, financial misstatements, and the fallout that follows. Brought to you by Levi and Korsinsky, a leading U.S. securities class action law firm. Subscribe now and visit ZLK.com to stay informed.

Bulls & Betrayal: Holding Wall Street Accountable pulls back the curtain on high-stakes financial scandals, securities fraud, and IPO disasters. Hosted by Anna and Nate—your no-BS guides to the world of Wall Street misfires—this show is for investors, financial sleuths, and anyone who wants to understand how companies can manipulate markets and get away with it… until they don’t. Each episode dives into real cases, like the Neumora Therapeutics meltdown, with sharp analysis, engaging storytelling, and zero legal jargon. Expect deep dives, unsparing commentary, and interviews that expose the truth behind the headlines. If you're into financial justice, investor rights, or just love a good corporate takedown, hit follow and join us. Powered by Levi & Korsinsky, a top U.S. securities class action firm. Learn more at ZLK.com.